Create the national formulary & negotiate drug prices

Months 0–18 for the initial formulary; continuous negotiation · National Formulary and Pricing Board; HTA InstituteDiscuss this step

Biosimilar and generic substitution

amendedYear 1Drugs & devices

Today

Slow biosimilar uptake because rebates favor brand biologics.

Under the plan

The national formulary prefers biosimilars and generics, with automatic pharmacy substitution.

Trade-off

Large savings; some patients must switch products, and brand makers lose market share faster.